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Background
Past experience and modeling suggest that, in most cases,
mass treatment strategies are not likely to succeed in
interrupting Plasmodium falciparum malaria transmis-
sion. However, this does not preclude their use to reduce
disease burden. Mass screening and treatment (MSAT) is
preferred to mass drug administration (MDA), as the lat-
ter involves massive over-use of drugs. This paper reports
simulations of the incremental cost-effectiveness (ICER)
of well-conducted MSAT campaigns as a strategy for
P. falciparum malaria disease burden reduction in set-
tings with varying receptivity (ability of the combined
vector population in a setting to transmit disease) and
access to case management.
Materials and methods
MSAT incremental cost-effectiveness ratios (ICERs) were
estimated in different sub-Saharan African settings using
simulation models of the dynamics of malaria and a litera-
ture-based MSAT cost estimate. Imported infections were
simulated at a rate of 2 per 1,000 population per annum.
These estimates were compared to the ICERs of scaling
up case management or insecticide treated net (ITN) cov-
erage in each baseline health system, in the absence of
MSAT.
Results
MSAT averted the most episodes, and resulted in the
lowest ICERs, in settings with a moderate level of disease
burden. At a low pre-intervention entomological inocula-
tion rate (EIR) of 2 infectious bites per adult per annum
(ibpapa), MSAT was never more cost-effective than scal-
ing up ITNs or case management coverage. However at
pre-intervention EIRs of 20 and 50 ibpapa and ITN cov-
erage levels of 40 or 60%, respectively, the ICER of
MSAT was similar to that of scaling up ITN coverage
further.
Conclusions
In all the transmission settings considered, achieving a
minimal level of ITN coverage is a “best buy”. At low
transmission, MSAT probably is not worth considering.
Instead, MSAT may be suitable at medium to high
levels of transmission and at moderate ITN coverage. If
undertaken as a burden-reducing intervention, MSAT
should be continued indefinitely and should comple-
ment, not replace, case management and vector control
interventions.
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